|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phase Ⅱ study of gefitinib in combination with FOLFOX-4(IFOX) in patient s with metastatic colorectal cancer显示文摘 | Fisher GA Kuo T Cho CD | 2004 | Proc Am Soc Clin Oncol2004，22，14： | 1 |
| 2 | Stroke显示文摘 | Donnan GA Fisher M Macleod M | 2008 | Lan- cet2008，37，： | 1 |
| 3 | Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance 显示文摘 | Yahanda AM Fisher GA Brophy NA | 1992 | J Clin Oncol1992，10，10： | 1 |
| 4 | Stroke显示文摘 | DONNAN GA FISHER M | 2008 | Lancet2008，371，9624： | 1 |
| 5 | Stroke显示文摘 | Donnan GA Fisher M Macleod M | 2008 | Lancet2008，371，9624： | 1 |
| 6 | Stroke显示文摘 | Donnan GA Fisher M Macleod M | 2008 | Lancet2008，371，9624： | 1 |
| 7 | Lancet显示文摘 | DONNAN GA FISHER M MACLEOD M | 2008 | Stroke2008，，371： | 1 |
| 8 | A phase Ⅱ study of gefitinib,5-fluorouracil,leucovorin,and oxaliplatin in previously untreated patients with metastatic colorectal cancer显示文摘 | Fisher GA Kuo T Ramsey M | | Clin Cancer Res0，14，21： | 1 |
| 9 | Phase Ⅰ study of an antisense oligonucletide to protein kinase C-alpha (ISIS3521/CGP 64128A) in patient with cancer 显示文摘 | Halsey J Fisher GA | 1999 | Clin Cancer Res1999，5，11： | 1 |
| 10 | A phase Ⅱ study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer显示文摘 | Fisher GA Kuo T Cho CD | 2004 | J Clin Oncol2004，22，： | 1 |
| 11 | stroke 显示文摘 | Donnan GA Fisher M Macleod M | 2008 | lancet2008，371，9624： | 1 |
| 12 | A phase II study of gefitinib in combina- tion with FOLFOX-4(IFOX) in patients with unresectable or metastat- ic colorectal cancer 显示文摘 | Fisher GA Kuo T Cho CD | 2004 | Proc 'Am Soc Oncol2004，22，14： | 1 |
| 13 | Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer显示文摘 | Cabehe E Fisher GA | 2007 | Expert Opin Invest Drugs2007，16，： | 1 |
| 14 | Use of the manual polybrene in the routine hospital laboratory显示文摘 | | 1983 | Transfusion1983，23，： | 1 |
| 15 | Stroke显示文摘 | Donnan GA Fisher M Macleod M | 2008 | Lancet2008，371，： | 1 |
| 16 | In vivo effects of biphosphates on the osteoclast mevalonate pathway显示文摘 | Fisher JE Rodn GA Reszka AA | | 0，，12： | 1 |
| 17 | Comparison of high- dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children 显示文摘 | Burghen GA Etteldorf JN Fisher JN | 1980 | Diabetes Care1980，3，1： | 1 |
| 18 | Five - year inci- dence, progression, and risk factors for age - related macular de- generation the age, gene/environment susceptibility study 显示文摘 | Jonasson F Fisher DE Eiriksdottir GA | 2014 | Ophthalmology2014，121，9： | 1 |
| 19 | Alendronate mechanism of action:geranylgeraniol,an inter-mediate in the mevalonate pathway,prevents inhibition of osteo-clast formation,bone resorption,and kinase activation in vitro显示文摘 | Fisher JE Rogers MJ Halasy JM Luckman SP Hughes DE Masarachia PJ Wesolowski G Russell RG Rodan GA Reszka AA | | 0，，： | 1 |
| 20 | Stroke显示文摘 | Donnan GA Fisher M Macleod M | 2008 | Lancet2008，371，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员